MANKIND / NSE / Biotechnology & Drugs
Mankind Pharma
1Y Price Trend
Key Information
Recommendations
RatingBuy
Target High2,726.75
Target Low1,909.9
Target Mean2.19
Target Median48.44
Risk Metrics
Overall RiskBalanced risk
Board Risk29.48
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Dr. Birendra Singh Assumes Role of Global Chief Quality Officer at Mankind Pharma hrtoday.in
Mankind Pharma management to attend IIFL conference in London scanx.trade
Mankind Pharma confirms no encumbrance on shares for FY26 scanx.trade
Mankind Pharma appoints Nilesh Kulkarni as group head-HR HR Katha
Bernstein backs Zydus, Lupin and Sun Pharma on innovation shift CNBC TV18
Stocks making the biggest moves midday: Zee, Mankind Pharma, Reliance Infra and more MSN
Number of shareholders of Mankind Pharma Ltd. – NSE:MANKIND TradingView
Nifty Pharma hits fresh record high even as market slips; Zydus Lifesciences, Mankind Pharma shares among top gainers MSN
© SharekeyX | Rusaka Technologies 2024-2026

